Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BackgroundWhen delivered through vaccination Vi-polysaccharide antigen of Salmonella enterica serotype Typhi protects against typhoid by inducing IgG anti-Vi antibodies. We aimed to determine whether the presence of antibodies following natural infection is associated with a lower incidence of typhoid fever in endemic regions.MethodsWe analyzed data from a cohort study of typhoid fever conducted in Dhaka, Bangladesh. Plasma IgG anti-Vi antibodies were measured using a standard enzyme-linked immunosorbent assay in random serosurveys of a population that had not previously received typhoid vaccination. Participants were followed for up to 20 months for culture-confirmed typhoid fever. The receiver operating characteristic (ROC) curve and Cox proportional hazard models were used to evaluate the associations between antibody levels and typhoid risk.ResultsThe ROC analysis revealed that IgG anti-Vi antibody titers were predictive of typhoid risk among the 8,261 serosurvey participants (area under the curve: 0·63; 95% confidence interval (CI): 0·58─0·67). Detection of any antibodies was associated with a lower risk of typhoid in crude analyses (hazard ratio (HR): 0·13; 95% CI: 0·03─0·52), though this association declined after adjustment (HR: 0·32; 95% CI: 0·07─1·40). A positive correlation was observed between IgG anti-Vi titers and age (correlation coefficient 0·35; p ConclusionsIn typhoid-endemic populations, IgG anti-Vi antibodies may indicate natural immunity to typhoid. The increasing seroprevalence with age suggests that these antibodies could serve as markers of cumulative past typhoid infections. Future research should explore these possibilities.Clinical trial numberNot applicable.

Original publication

DOI

10.1186/s12879-025-10548-8

Type

Journal

BMC infectious diseases

Publication Date

01/2025

Volume

25

Addresses

International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. farhanak@icddrb.org.

Keywords

Humans, Salmonella typhi, Typhoid Fever, Polysaccharides, Bacterial, Immunoglobulin G, Typhoid-Paratyphoid Vaccines, Antibodies, Bacterial, Enzyme-Linked Immunosorbent Assay, Incidence, Cohort Studies, Seroepidemiologic Studies, Adolescent, Adult, Middle Aged, Child, Child, Preschool, Infant, Bangladesh, Female, Male, Young Adult